Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET).
Lyndon Marc EvansAbhishek Shankar ChandramouliMads FaurbyKasper Sommer MatthiessenPhillip Bredahl MogensenSubodh VermaPublished in: Diabetes, obesity & metabolism (2022)
These findings suggest that, in US patients with T2D and a CVD-related hospitalization, the added medical cost of treatment with GLP-1 RAs is offset by lower inpatient and outpatient care costs, resulting in budget neutrality against SoC.